Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pear Therapeutics Plans To Accelerate Reimbursement For Digital Therapeutics With $80M Series D

Dec 08 2020

• By Marion Webb

Finance. Venture capital. Financial services.

Related Companies

Pear Therapeutics, Inc.

Novartis AG

Additional Topics

Digital Health Financing Launches Research & Development Commercial Neurology Medical Device

More from Digital Technologies

More from Medtech Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.